Olanzapine in the treatment of adolescent psychotic patients;Olanzapin in der behandlung jugendlicher psychotischer patienten

Psychopharmakotherapie

Volumn 8, Issue 2, 2001, Pages 71-75

  Dittmann, R W ^a   Junghanss J ^a  

^a LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Efficacy and tolerability; Olanzapine treatment; Psychotic adolescents; Retrospective chart review

Indexed keywords

OLANZAPINE;

ADOLESCENCE; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PSYCHOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; WEIGHT GAIN;

EID: 0034985592     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Risperidone in adolescents with schizophrenia: An open pilot study
2. Efficacy of olanzapine: An overview of pivotal clinical trials
3. Safety of olanzapine
4. Olanzapin. Ein neues neuroleptikum mit "atypischem" wirkungsprofil
5. In vitro and in vivo biochemistry of olanzapine
6. Treatment of children and adolescents with Olanzapine - A review
7. Die basisdokumentation kinder- und jugendpsychiatrie
8. Antipsychotic medications in children and adolescents
9. Olanzapine in PDD
10. An open-label study of olanzapine in children with pervasive developmental disorder
11. Open-label olanzapine treatment in five preadolescent children
12. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison
13. Case study: Risperidone-induced hepatotoxicity in pediatric patients
14. Case series: Spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia
15. Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
16. Olanzapine in the treatment of early onset schizophrenia in children and adolescents
17. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
18. Child psychiatry comes of age: Growing sophistication, evolving strategies
19. An open trial of clozapine in thirty-six adolescents with schizophrenia
20. Olanzapine in adolescents with a psychotic disorder
21. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia
22. Treatment and outcomes in adolescents with schizophrenia
23. Olanzapine in the treatment of adolescent acute mania: A report of seven cases
24. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia
25. Clinical decision making in child and adolescent psychopharmacology